These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30815604)

  • 41. Effect of variation in BDNF Val(66)Met polymorphism, smoking, and nicotine dependence on symptom severity of depressive and anxiety disorders.
    Jamal M; Van der Does W; Penninx BW
    Drug Alcohol Depend; 2015 Mar; 148():150-7. PubMed ID: 25618300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions between the combined genotypes of 5-HTTLPR and BDNF Val66Met polymorphisms and parenting on adolescent depressive symptoms: A three-year longitudinal study.
    Wang M; Tian X; Zhang W
    J Affect Disord; 2020 Mar; 265():104-111. PubMed ID: 32090731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Relationship Among BDNF Val66Met Polymorphism, Plasma BDNF Level, and Trait Anxiety in Chinese Patients With Panic Disorder.
    Chu L; Sun X; Jia X; Li D; Gao P; Zhang Y; Li J
    Front Psychiatry; 2022; 13():932235. PubMed ID: 35815047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The functional epistasis of 5-HTTLPR and BDNF Val66Met on emotion processing: a preliminary study.
    Outhred T; Das P; Dobson-Stone C; Griffiths K; Felmingham KL; Bryant RA; Malhi G; Kemp AH
    Brain Behav; 2012 Nov; 2(6):778-88. PubMed ID: 23170240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.
    Verhagen M; van der Meij A; van Deurzen PA; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
    Mol Psychiatry; 2010 Mar; 15(3):260-71. PubMed ID: 18852698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among Polish population: a case-control study.
    Sieminska A; Buczkowski K; Jassem E; Tkacz E
    BMC Med Genet; 2008 Aug; 9():76. PubMed ID: 18691405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice.
    Lee BG; Anastasia A; Hempstead BL; Lee FS; Blendy JA
    Nicotine Tob Res; 2015 Dec; 17(12):1428-35. PubMed ID: 25744957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association between BDNF C270T genetic variants and smoking in patients with mental disorders and in healthy controls.
    Pivac N; Nedic Erjavec G; Sagud M; Nikolac Perkovic M; Tudor L; Uzun S; Kovacic Petrovic Z; Konjevod M; Dvojkovic A; Kozumplik O; Svob Strac D; Peraica T; Mimica N; Zivkovic M; Hirasawa-Fujita M; Domino EF
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110452. PubMed ID: 34637871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of polymorphisms of serotonin transporter promoter (5-HTTLPR) and brain derived neurotrophic factor gene (G196A rs6265) on the risk of major depressive disorder in the Chinese Han population.
    Sun N; Yang CX; Liu ZF; Li XR; Xu Y; Zhang KR
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1852-9. PubMed ID: 27212180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The BDNF Val66Met polymorphism is associated with rumination in healthy adults.
    Beevers CG; Wells TT; McGeary JE
    Emotion; 2009 Aug; 9(4):579-84. PubMed ID: 19653783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactive effect of 5-HTTLPR and BDNF polymorphisms on amygdala intrinsic functional connectivity and anxiety.
    Loewenstern J; You X; Merchant J; Gordon EM; Stollstorff M; Devaney J; Vaidya CJ
    Psychiatry Res Neuroimaging; 2019 Mar; 285():1-8. PubMed ID: 30711709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.
    Naoe Y; Shinkai T; Hori H; Fukunaka Y; Utsunomiya K; Sakata S; Matsumoto C; Shimizu K; Hwang R; Ohmori O; Nakamura J
    Neurosci Lett; 2007 Mar; 415(2):108-12. PubMed ID: 17267117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study.
    Buchmann AF; Hellweg R; Rietschel M; Treutlein J; Witt SH; Zimmermann US; Schmidt MH; Esser G; Banaschewski T; Laucht M; Deuschle M
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):902-9. PubMed ID: 23058261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BDNF Val66Met polymorphism, energy intake and BMI: a follow-up study in schoolchildren at risk of eating disorders.
    Arija V; Ferrer-Barcala M; Aranda N; Canals J
    BMC Public Health; 2010 Jun; 10():363. PubMed ID: 20573217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.
    Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
    Hum Psychopharmacol; 2010 Mar; 25(2):145-52. PubMed ID: 20196181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BDNF Val66Met and DRD2 Taq1A polymorphisms interact to influence PTSD symptom severity: a preliminary investigation in a South African population.
    Hemmings SM; Martin LI; Klopper M; van der Merwe L; Aitken L; de Wit E; Black GF; Hoal EG; Walzl G; Seedat S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():273-80. PubMed ID: 23103549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is Brain-Derived Neurotrophic Factor Associated With Smoking Initiation? Replication Using a Large Finnish Population Sample.
    Korhonen T; Loukola A; Hällfors J; Salomaa V; Kaprio J
    Nicotine Tob Res; 2020 Feb; 22(2):293-296. PubMed ID: 30329132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.
    Yoshimura R; Kishi T; Suzuki A; Umene-Nakano W; Ikenouchi-Sugita A; Hori H; Otani K; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1022-5. PubMed ID: 21338649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
    Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
    Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BDNF Val66Met Polymorphism: Suggested Genetic Involvement in Some Children with Learning Disorder.
    Elhadidy ME; Kilany A; Gebril OH; Nashaat NH; Zeidan HM; Elsaied A; Hashish AF; Abdelraouf ER
    J Mol Neurosci; 2023 Jan; 73(1):39-46. PubMed ID: 36550387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.